The US FTC employs a creative remedy, requiring the offer of divestiture to determine the existence of a viable alternative purchaser, before approving the merger of acute care hospitals (King’s Daughters Hospital / Scott & White)

After a decade of what was perceived by many as relatively restrained merger enforcement, the Obama administration has repeatedly and vocally vowed to “reinvigorate antitrust enforcement” and to “take effective action to stop or restructure mergers that are likely to harm consumer[s]” [1]. Many have interpreted this call to action to mean that the U.S. antitrust agencies will more actively challenge proposed and consummated transactions that are arguably anticompetitive. Given the agencies’ historical preference for structural remedies (rather than behavioral or conduct remedies) [2], the expectation has been that the renewed enforcement efforts would force merging parties to accept broad divestitures or face the real risk of litigation. While it is still too early to reach broad

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

  • Cleary Gottlieb Steen & Hamilton (Cologne)
  • Cleary Gottlieb Steen & Hamilton (Washington)

Citation

Patrick Bock, Jeremy J. Calsyn, The US FTC employs a creative remedy, requiring the offer of divestiture to determine the existence of a viable alternative purchaser, before approving the merger of acute care hospitals (King’s Daughters Hospital / Scott & White), 23 décembre 2009, e-Competitions December 2009, Art. N° 53241

Visites 265

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues